Marrs Tom, Sim Kathleen
Department of Paediatric Allergy, School of Immunology & Microbial Sciences, King's College London, London, United Kingdom.
Children's Allergies Department, Guy's and St Thomas' NHS Foundation Trust, St Thomas' Hospital, Westminster Bridge Road, London, United Kingdom.
Curr Pediatr Rev. 2018;14(3):156-163. doi: 10.2174/1573396314666180507120424.
The growing burden of food allergy is being driven by environmental exposures and the potential role of gut micro-organisms (or 'microbiota') is hotly debated. Early culture-based studies outlined that imbalances between commensal gut constituents ('dysbiosis') early in life may raise the risk of developing allergic disease. A number of studies using animal models describe mechanisms by which specific bacterial taxa within the gut microbiota, their diversity and dietary substrates such as fibre may promote oral tolerance. Next-generation sequencing now allows the detailed characterization of the microbiota in relation to epidemiological exposures and clinical food allergy status in humans. Faecal samples from one birth cohort characterized for food allergy status have been sequenced and showed less gut microbiota richness amongst three month infants who later developed food sensitization at one year. A large cross-sectional survey of young children with milk allergy showed that greater gut microbiota diversity and enrichment of Clostridia and Firmicutes phyla during early infancy is associated with greater likelihood of out-growing milk allergy by eight years of age. Case control studies are limited to selecting participants from amongst hospital patients and have only allowed comparison of heterogeneous groups. To assess whether infants' gut microbiota may predispose towards the development of food allergy, cohort studies must be undertaken to evaluate gut microbiota development from early in infancy and prospectively characterise patterns according to whether challenge proven food allergy later develops, whilst adjusting for atopic dermatitis, dietary and antibiotic exposures.
食物过敏负担的日益加重是由环境暴露所驱动的,而肠道微生物(或“微生物群”)的潜在作用也备受争议。早期基于培养的研究表明,生命早期肠道共生成分之间的失衡(“生态失调”)可能会增加患过敏性疾病的风险。一些使用动物模型的研究描述了肠道微生物群中的特定细菌分类群、它们的多样性以及膳食纤维等饮食底物促进口服耐受的机制。新一代测序技术现在能够详细描述与人类流行病学暴露和临床食物过敏状态相关的微生物群特征。对一个以食物过敏状态为特征的出生队列的粪便样本进行测序后发现,在三个月大时肠道微生物群丰富度较低的婴儿,在一岁时更容易出现食物过敏。一项针对牛奶过敏幼儿的大型横断面调查显示,婴儿早期肠道微生物群多样性更高以及梭菌门和厚壁菌门富集,与到八岁时牛奶过敏自愈的可能性更大有关。病例对照研究仅限于从医院患者中选择参与者,并且只允许对异质性群体进行比较。为了评估婴儿的肠道微生物群是否可能易患食物过敏,必须开展队列研究,从婴儿早期开始评估肠道微生物群的发育情况,并根据是否随后发生经激发试验证实的食物过敏前瞻性地描述其模式,同时对特应性皮炎、饮食和抗生素暴露进行调整。